Andrea E. Van Der Meulen
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
The decline of 6-thioguanine nucleotides is not linked to impaired efficacy or safety of thiopurines in pregnant women with inflammatory bowel disease.
Journal: British journal of clinical pharmacology
Published: October 01, 2025
Filgotinib Is an Effective and Safe Treatment Option for Difficult-To-Treat Ulcerative Colitis: Real-World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry.
Journal: United European gastroenterology journal
Published: July 24, 2025
Current Status, Challenges, and Future Directions in Crohn's Disease.
Journal: Journal of clinical medicine
Published: July 18, 2024
Metagenomic global survey and in-depth genomic analyses of Ruminococcus gnavus reveal differences across host lifestyle and health status.
Journal: Nature communications
Published: July 12, 2024
Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease.
Journal: Alimentary pharmacology & therapeutics
Published: February 08, 2023
Letter: tricky reactions to switch back from subcutaneous to intravenous vedolizumab in inflammatory bowel disease patients-authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: January 19, 2023
Impact of timing of primary ileocecal resection on prognosis in patients with Crohn's disease.
Journal: BJS open
Published: January 17, 2023
Retreatment with anti-tumor necrosis factor therapy in combination with an immunomodulator for recurrence of Crohn's disease after ileocecal resection results in prolonged continuation as compared to anti-tumor necrosis factor monotherapy.
Journal: European journal of gastroenterology & hepatology
Published: December 05, 2022
Reply.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: July 22, 2022
Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases.
Journal: Alimentary pharmacology & therapeutics
Published: April 26, 2022
Indications, Postoperative Management, and Long-term Prognosis of Crohn's Disease After Ileocecal Resection: A Multicenter Study Comparing the East and West.
Journal: Inflammatory bowel diseases
Published: September 25, 2021
Last Updated: 09/26/2026